Putting hearts at the heart of healthcare strategy

Cardiovascular disease (CVD) remains the leading cause of death globally, claiming 20.5 million lives in 2021. In the UK, it accounts for a quarter of all deaths and severely strains healthcare systems.

Progress in tackling CVD is being made thanks to better screening, public health initiatives, new treatment innovations and digital health solutions. However, lifestyle-driven prevalence and disparities in care persist and the global burden of CVD is projected to rise by 90% by 2050, underscoring the need for deeper investment to drive transformative innovation.

Navigating Challenges and Opportunities

Our clients are tasked with bringing novel therapies to market within this complex environment. In addition to external factors, biotech commercial and medical teams often operate with limited internal resources, balancing competing priorities.

At Aurora, we specialise in global product commercialisation. We focus on seamless integration with our clients to provide integrated strategic, medical, patient-focused and commercial expertise, underpinned by proven methodologies and case studies.

Four reasons why Aurora is an essential strategic partner for industry working in CVD:

1. Integrated offering: Our team includes experts across strategy, creative, communications, marketing and patient engagement who integrate to drive measurable progress for our clients.  
2. Proven track record: We understand the CVD landscape and work with our clients to generate strategic solutions thanks to our in-depth experience with chronic heart failure and lipid disorders.
3. Precision in client service: We pride ourselves in working as an extension of your team, operating with agility and a collaborative ethos to co-create solutions that drive lasting impact in CVD.
4. Local insight drives Global impact: CVD is a truly Global health priority, requiring joined up solutions. With offices in London, Washington D.C., New York and Chicago and a network of healthcare specialist agencies in 60+ markets, we create Global impact by connecting local expertise and insight.

A Call to Action

The future of CVD care is full of potential, but real progress depends on collaboration, innovation, and clear, impactful communication. As personalised medicine, AI-driven diagnostics, and regenerative therapies redefine the landscape, our promise is to be your dedicated strategic partner, helping to shape the landscape for innovation to succeed by fostering stakeholder understanding and action.

Because matters of the heart are at the heart of what matters in healthcare.

Keen to learn more?

This is the first in a series of articles on CVD. The next will focus on our experience in chronic heart failure and lipid disorder. If you would like to set up a call to learn more, please contact me at stephen.ofarrell@auroracomms.com.